Literature DB >> 19853827

Developing outcome measures for paediatric rheumatic diseases.

Hermine I Brunner1, Angelo Ravelli.   

Abstract

This review provides a theoretical background and approach for developing outcome measures that are often used to assess the state and course of paediatric rheumatic diseases. It describes the important steps in scale development such as item generation and reduction, the assessment of scale reliability and various forms of validation. The second part of this review described the newly developed outcome measures as well as their state of validation. These outcome measures include therapeutic response measures, composite disease activity scores for juvenile idiopathic arthritis (JIA), global disease activity tools for juvenile systemic lupus erythematosus and juvenile dermatomyositis, disease status measures in JIA, measures of physical function, measures of health-related quality of life, clinical measures of damage and radiographic scoring systems in JIA.

Entities:  

Mesh:

Year:  2009        PMID: 19853827     DOI: 10.1016/j.berh.2009.07.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  10 in total

Review 1.  Outcome Scores in Pediatric Rheumatology.

Authors:  Gabriella Giancane; Silvia Rosina; Alessandro Consolaro; Nicolino Ruperto
Journal:  Curr Rheumatol Rep       Date:  2021-03-08       Impact factor: 4.592

2.  Paediatric rheumatology: Juvenile idiopathic arthritis--are biologic agents effective for pain?

Authors:  Alessandro Consolaro; Angelo Ravelli
Journal:  Nat Rev Rheumatol       Date:  2013-07-02       Impact factor: 20.543

Review 3.  Juvenile idiopathic arthritis: new insights into classification, measures of outcome, and pharmacotherapy.

Authors:  Michael W Beresford
Journal:  Paediatr Drugs       Date:  2011-06-01       Impact factor: 3.022

4.  A Study Protocol for the Management of Children With Juvenile Idiopathic Arthritis Based on ePROs.

Authors:  Biyu Shen; Songsong Shi; Hengmei Cui; Yunyun Li; Haoyang Chen; Huan Jin; Jia Xu; Zuojia Liu; Yanliang Jin
Journal:  Front Pediatr       Date:  2022-07-06       Impact factor: 3.569

Review 5.  Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases.

Authors:  Erkan Demirkaya; Alessandro Consolaro; Hafize Emine Sonmez; Gabriella Giancane; Dogan Simsek; Angelo Ravelli
Journal:  Curr Rheumatol Rep       Date:  2016-02       Impact factor: 4.592

6.  A new biopsychosocial and clinical questionnaire to assess juvenile idiopathic arthritis: JAB-Q.

Authors:  Edibe Unal; Ezgi Deniz Batu; Hafize Emine Sonmez; Zehra Serap Arici; Gamze Arin; Nur Banu Karaca; Erdal Sag; Selcan Demir; Duygu Aydin Hakli; Aykut Ozcadirci; Fatma Birgul Oflaz; Reha Alpar; Yelda Bilginer; Seza Ozen
Journal:  Rheumatol Int       Date:  2018-06-05       Impact factor: 2.631

Review 7.  Disease activity measures in paediatric rheumatic diseases.

Authors:  Nadia J Luca; Brian M Feldman
Journal:  Int J Rheumatol       Date:  2013-09-08

Review 8.  Clinical outcome measures in juvenile idiopathic arthritis.

Authors:  Alessandro Consolaro; Gabriella Giancane; Benedetta Schiappapietra; Sergio Davì; Serena Calandra; Stefano Lanni; Angelo Ravelli
Journal:  Pediatr Rheumatol Online J       Date:  2016-04-18       Impact factor: 3.054

Review 9.  Juvenile Idiopathic Arthritis: Diagnosis and Treatment.

Authors:  Gabriella Giancane; Alessandro Consolaro; Stefano Lanni; Sergio Davì; Benedetta Schiappapietra; Angelo Ravelli
Journal:  Rheumatol Ther       Date:  2016-08-12

Review 10.  Mitochondrial disorders in children: toward development of small-molecule treatment strategies.

Authors:  Werner Jh Koopman; Julien Beyrath; Cheuk-Wing Fung; Saskia Koene; Richard J Rodenburg; Peter Hgm Willems; Jan Am Smeitink
Journal:  EMBO Mol Med       Date:  2016-04-01       Impact factor: 12.137

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.